These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


282 related items for PubMed ID: 25326473

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Characteristics of pediatric C3 glomerulopathy with decreased factor H in 3 cases].
    He RJ, Xiao HJ, Wang SX, Guan N, Yao Y, Ding J.
    Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):939-43. PubMed ID: 23324154
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Complement system regulation and C3 glomerulopathy].
    Xiao HJ, He RJ.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr 18; 45(2):323-6. PubMed ID: 23591359
    [Abstract] [Full Text] [Related]

  • 7. C3 Glomerulonephritis With Multiple Mutations in Complement Factor H.
    Dalili N, Behnam B, Vali F, Parvin M, Torbati P, Rasaii N, Samadian F, Ahmadpoor P.
    Iran J Kidney Dis; 2018 Nov 18; 12(6):376-381. PubMed ID: 30595568
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of C3 in C3 glomerulopathy.
    Sethi S, Vrana JA, Fervenza FC, Theis JD, Sethi A, Kurtin PJ, Zhang Y, Smith RJH.
    Nephrol Dial Transplant; 2017 Mar 01; 32(3):459-465. PubMed ID: 27507892
    [Abstract] [Full Text] [Related]

  • 10. The MFHR1 Fusion Protein Is a Novel Synthetic Multitarget Complement Inhibitor with Therapeutic Potential.
    Michelfelder S, Fischer F, Wäldin A, Hörle KV, Pohl M, Parsons J, Reski R, Decker EL, Zipfel PF, Skerka C, Häffner K.
    J Am Soc Nephrol; 2018 Apr 01; 29(4):1141-1153. PubMed ID: 29335241
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of Targeted Complement Inhibition in Experimental C3 Glomerulopathy.
    Ruseva MM, Peng T, Lasaro MA, Bouchard K, Liu-Chen S, Sun F, Yu ZX, Marozsan A, Wang Y, Pickering MC.
    J Am Soc Nephrol; 2016 Feb 01; 27(2):405-16. PubMed ID: 26047789
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.